Related Experiment Videos
Florida's undeclared epidemic: malignant melanoma
D Kamath1, A B Cantor, F Glass
1Cutaneous Oncology Program Moffitt Cancer Center, USF, Tampa, USA.
The Journal of the Florida Medical Association
|March 1, 1997
Summary
Melanoma in Florida is diagnosed at advanced stages, unlike global trends. While mortality decreases due to better treatments, early detection efforts are crucial for improving patient outcomes.
Area of Science:
- Dermatology
- Oncology
- Public Health
Background:
- Melanoma diagnosis in Florida trends towards advanced stages, contrary to global early detection trends.
- Advanced stage melanoma is characterized by thicker lesions, ulceration, and increased vertical growth.
- Key prognostic factors like tumor thickness and ulceration have remained constant in Florida patients from 1987-1994.
Purpose of the Study:
- To analyze melanoma diagnosis trends and prognostic factors in Florida.
- To investigate the relationship between diagnostic stage, treatment, and mortality rates.
- To propose strategies for improving early melanoma detection in Florida.
Main Methods:
- Retrospective study of 1,626 cutaneous melanoma patients at H. Lee Moffitt Cancer Center.
- Analysis of prognostic factors including tumor thickness, Clark level, and ulceration over an eight-year period (1987-1994).
- Correlation of diagnostic stage and treatment effectiveness with mortality rates.
Main Results:
- Melanoma continues to be diagnosed at advanced stages in Florida.
- Despite constant tumor thickness, mortality rates have decreased, suggesting improved treatment efficacy.
- Prognostic factors have remained stable over the study period.
Conclusions:
- Early detection of malignant melanoma requires significant improvement in Florida.
- Statewide public and professional education programs are essential for earlier diagnosis.
- Targeted screening programs for high-risk populations (e.g., Caucasian with skin types 1-2) could enhance early detection and patient prognosis.